Luye Pharma

Luye Pharma Group, under the Luye Life Sciences Group, is committed to the research and development, manufacturing, and sales of innovative drugs. Its more than 30 marketed products cover major therapeutic areas such as oncology, central nervous system, cardiovascular, and diabetes — which represent the largest and fastest-growing treatment fields. The company’s business spans key pharmaceutical markets and emerging markets worldwide, including China, the United States, Europe, Australia, and Japan and South Korea. Luye Pharma has established a globally aligned R&D system and maintains an internationally advanced position in novel drug delivery systems such as microspheres, liposomes, transdermal drug delivery, and subcutaneous implants.